Per this agreement, approximately 4.1 million members associated with more than 200 health insurers, self-funded employers, and other payors of health care services will be able to access Response Genetics’ suite of molecular predictive testing at a
Read More
New approach subtypes cancers by shared genetic effects; a step toward personalized medicine.
Read More
The event showcases the latest in cancer and genetic testing, molecular diagnostics, and screening for obesity-related diseases.
Read More
The array of products ranges from mouse monoclonal antibodies to pathology information systems.
Read More
Perhaps some of these new products will be a good fit for your lab.
Read More